NasdaqGS - Nasdaq Real Time Price USD
Mineralys Therapeutics, Inc. (MLYS)
15.42
+0.07
+(0.46%)
As of 1:11:48 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 6 |
| Avg. Estimate | -0.75 | -0.76 | -3.06 | -3.34 |
| Low Estimate | -0.86 | -0.92 | -3.59 | -4.53 |
| High Estimate | -0.6 | -0.55 | -2.43 | -2.32 |
| Year Ago EPS | -0.83 | -1.13 | -3.66 | -3.06 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -- | -- | -- | 11.03M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 51.25M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.7 | -0.83 | -1.08 | -0.98 |
| EPS Actual | -0.83 | -1.13 | -0.98 | -0.79 |
| Difference | -0.13 | -0.3 | 0.1 | 0.19 |
| Surprise % | -18.57% | -35.44% | 9.02% | 19.55% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.75 | -0.76 | -3.06 | -3.34 |
| 7 Days Ago | -0.94 | -0.86 | -3.74 | -3.82 |
| 30 Days Ago | -0.94 | -0.86 | -3.74 | -3.82 |
| 60 Days Ago | -0.99 | -0.9 | -3.89 | -3.96 |
| 90 Days Ago | -1 | -0.95 | -3.91 | -3.59 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 3 | 3 | 4 |
| Up Last 30 Days | 4 | 3 | 3 | 4 |
| Down Last 7 Days | -- | 1 | 1 | -- |
| Down Last 30 Days | -- | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MLYS | 9.40% | 32.92% | 16.45% | -9.06% |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/13/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 4/2/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/10/2025 |
| Reiterates | Guggenheim: Buy to Buy | 2/24/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 2/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/13/2025 |
Related Tickers
TYRA Tyra Biosciences, Inc.
9.84
-1.55%
MRUS Merus N.V.
41.37
-0.47%
GLUE Monte Rosa Therapeutics, Inc.
4.1100
+3.27%
SRRK Scholar Rock Holding Corporation
29.92
-2.06%
APGE Apogee Therapeutics, Inc.
40.30
-0.79%
PRAX Praxis Precision Medicines, Inc.
36.38
-1.73%
LYEL Lyell Immunopharma, Inc.
0.4031
-2.87%
AKRO Akero Therapeutics, Inc.
38.26
-1.58%
CGEM Cullinan Therapeutics, Inc.
7.66
+2.13%
ELVN Enliven Therapeutics, Inc.
16.30
-3.32%